During the past decade, CHU Pontchaillou - Hématologie Clinique BMT-HC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Pontchaillou - Hématologie Clinique BMT-HC" #1 collaborator was "AbbVie" with 3 trials as a collaborator, "Acute Leukemia French Association" with 2 trials as a collaborator, "Janssen-Cilag Ltd." with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "CHU Pontchaillou - Hématologie Clinique BMT-HC" are "Acute Myeloid Leukemia" (4 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloblastic Leukemia" (1 trials), "CLL/SLL" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "CHU Pontchaillou - Hématologie Clinique BMT-HC" in a lesser frequency.

Most popular intervention types in "CHU Pontchaillou - Hématologie Clinique BMT-HC" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (4 trials), "Glofitamab" (3 trials), "Tocilizumab" (3 trials), "ACA Continuation" (1 trials) and "Blinatumomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Pontchaillou - Hématologie Clinique BMT-HC" are 17 trials for "All" genders.

Currently, there are NaN active trials in "CHU Pontchaillou - Hématologie Clinique BMT-HC". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CHU Pontchaillou - Hématologie Clinique BMT-HC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Pontchaillou - Hématologie Clinique BMT-HC, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".